None
DE
Orion Oyj (ORINF) versus Its Rivals Head-To-Head Review
['Joseph Griffin']
Ticker Report
Net Margins Return on Equity Return on Assets Orion Oyj N/A N/A N/A Orion Oyj Competitors -2,505.37% -250.75% -16.90%DividendsOrion Oyj pays an annual dividend of $1.25 per share and has a dividend yield of 1.5%.
Get Orion Oyj alerts:Institutional & Insider Ownership18.8% of Orion Oyj shares are owned by institutional investors.
Earnings and ValuationGross Revenue Net Income Price/Earnings Ratio Orion Oyj N/A N/A 51.50 Orion Oyj Competitors $3.52 billion $3.11 billion 540.27This table compares Orion Oyj and its peers top-line revenue, earnings per share and valuation.
SummaryOrion Oyj peers beat Orion Oyj on 6 of the 9 factors compared.
It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease.